Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
Clodagh Towns(National Hospital for Neurology and Neurosurgery), Huifang Shang(Sichuan University), J Solle(Michael J. Fox Foundation), Zaruhi Tavadyan(National Institute of Health), Sarah Camargos(Universidade Federal de Minas Gerais), Tarek Antar(National Institutes of Health), Kristin Levine(National Institutes of Health), Julie Joubert(King's College London), Miguel E. Rentería(The University of Queensland), Madeleine Richer(King's College London), Alexander Zimprich(Ludwig-Maximilians-Universität München), M. Leonor Bustamante(University of Chile), Edward A. Fon(Montreal Neurological Institute and Hospital), Hampton L. Leonard(National Institutes of Health), Bradford Casey(Michael J. Fox Foundation), Paula Saffie Awad(Universidade Federal do Rio Grande do Sul), Oury Monchi(University of Chile), Claire Wegel(Indiana University School of Medicine), Sulev Kõks(University of Tartu), Marcelo Kauffman(Hospital Ramos Mejía), Pedro Chaná(Central South University), Mary B. Makarious(National Institutes of Health), Manuela Tan(Oslo University Hospital), Patricio Olguı́n(University of Chile), Laurel A. Screven(National Institutes of Health), Artur Francisco Schumacher Schuh(Universidade Federal do Rio Grande do Sul), Alejandro Martínez-Carrasco(King's College London), Samson Khachatryan(A. Alikhanyan National Laboratory), Eleanor J. Stafford(King's College London), Carlos Roberto de Mello Rieder(Universidade Federal do Rio Grande do Sul), Cornelis Blauwendraat(National Institute of Neurological Disorders and Stroke), Melina Ellis(The University of Sydney), Kishore R. Kumar(The University of Sydney), Huw R. Morris(University College London), Caroline B. Pantazis(National Institute of Neurological Disorders and Stroke), Dan Vitale(National Institutes of Health), Beisha Tang(Central South University), Hirotaka Iwaki(National Institute of Neurological Disorders and Stroke), Emilia Gatto(Universidad de Buenos Aires), Benjamin Pizarro Galleguillos(Fundación Chile), Ted Fon(McGill University), Andrew Singleton(Short and Associates (United States)), Dena Hernández(Framingham Heart Study), Marcelo Miranda(Fundación Chile), Julie Hunter(Garvan Institute of Medical Research), Simona Jasaityte(King's College London), Vítor Tumas(Universidade de Ribeirão Preto), Mike A. Nalls(National Institutes of Health), Claire E. Shepherd(UNSW Sydney)
Cited by 39
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
Ubiquitin is phosphorylated by PINK1 to activate parkin
|Nature|2014|1.5k